Nomura Asset Management
NVAX icon

Nomura Asset Management’s Novavax NVAX Stock Holding History

Nomura Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.5K Buy
+2,600
New +$23.3K ﹤0.01% 1245
2022
Q2 		– Sell
-13,990
Closed -$1.03M – 1561
2022
Q1 		$1.03M Hold
13,990
– – 0.01% 834
2021
Q4 		$2M Buy
13,990
+1,100
+9% +$189K 0.01% 746
2021
Q3 		$2.67M Hold
12,890
– – 0.02% 637
2021
Q2 		$2.74M Buy
+12,890
New +$2.36M 0.02% 647

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Nomura Asset Management's NVAX Position: Q2 2026 in Review

Nomura Asset Management opened a new position in Novavax (NVAX) in Q2 2026: 2,600 shares worth $24.5K. The stake represents ﹤0.01% of the portfolio and ranks #1245 among its holdings. This is a return to the name: Nomura Asset Management previously reported a position in NVAX as recently as Q1 2022.

Nomura Asset Management first reported a position in NVAX in Q2 2021 and has held it in 5 quarters since. The position peaked at $2.74M in Q2 2021. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Nomura Asset Management held 2,600 shares of Novavax worth $24.5K as of Q2 2026.
  • Novavax was a new Nomura Asset Management position in Q2 2026.
  • Novavax made up ﹤0.01% of Nomura Asset Management's portfolio in Q2 2026, its #1245 holding.
  • Nomura Asset Management first reported a position in Novavax in Q2 2021 and has held it in 5 quarters since.
  • Nomura Asset Management's Novavax position peaked at $2.74M in Q2 2021.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.